Ensysce Biosciences (ENSC) Common Equity (2017 - 2025)
Ensysce Biosciences' Common Equity came in at $3.21 million for Q4 2025, down 4.9% from $3.38 million a year earlier but up 167.1% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Common Equity (2017 - 2025) Analysis & Trends
Going back to Q4 2017, Ensysce Biosciences' Common Equity data covers 33 quarters.
- Going back by year, Common Equity was $3.38 million in FY2024, -$651,267 in FY2023, -$4.03 million in FY2022 and -$8.16 million in FY2021.
- The five-year range for quarterly Common Equity is -$8.16 million (Q4 2021) to $6.58 million (Q3 2024).
- Year-over-year, Common Equity increased in two of the last six quarters, with growth averaging 67.9%.
- Business Quant data shows ENSC's Common Equity at $1.2 million (Q3 2025), $3.06 million (Q2 2025) and $2.72 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Ensysce Biosciences | 901,219.67 | -10.35 Mn | - | 3.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 3.06 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 6.58 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | -651,267.00 |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 3.79 Mn |
| Mar 31, 2023 | -152,424.00 |
| Dec 31, 2022 | -4.03 Mn |
| Sep 30, 2022 | -6.42 Mn |
| Jun 30, 2022 | -797,578.00 |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | -8.16 Mn |
| Sep 30, 2021 | -385,287.00 |
| Jun 30, 2021 | 5.17 Mn |
| Mar 31, 2021 | -7.30 Mn |
API Access
Ensysce Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();